FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

Blood Products Advisory Committee
July 13, 2006

Briefing Information

Nabi Biopharmaceuticals

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Hepatitis B Immune Globulin (Human) Intravenous Briefing Material

References (Copyrighted Material)

FDA

FDA Review of Nabi Biopharmaceuticals' Hepatitis B IGIV for Prevention of Recurrent HBV Disease after Orthotopic Liver Transplantation

Page last updated July 11, 2006 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management